900181851	900181851	CD	B-NP	O
|	|	NNP	I-NP	O
WH	WH	NNP	I-NP	O
|	|	VBD	B-VP	O
05179465	05179465	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
8887804	8887804	CD	B-NP	O
|	|	CC	I-NP	O
3/12/2006	3/12/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
hyperkalemia	hyperkalemia	NN	I-NP	O
|	|	NN	I-NP	O
Unsigned	Unsigned	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/8/2006	4/8/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Unsigned	Unsigned	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/16/2006	7/16/2006	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
CALVERY	CALVERY	NNP	B-NP	O
,	,	,	O	O
BRADY	BRADY	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSES	DIAGNOSES	NNP	I-NP	O
:	:	:	O	O
Congestive	Congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
,	,	,	O	O
pneumonia	pneumonia	NN	B-NP	O
.	.	.	O	O

LIST	LIST	NN	B-NP	O
OF	OF	IN	B-PP	O
OTHER	OTHER	NNP	B-NP	O
PROBLEMS	PROBLEMS	NNP	I-NP	O
AND	AND	CC	O	O
DIAGNOSES	DIAGNOSES	NNP	B-NP	O
CONSIDERED	CONSIDERED	NNP	I-NP	O
DURING	DURING	NNP	I-NP	O
THIS	THIS	NNP	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Bronchoalveolar	Bronchoalveolar	JJ	B-NP	O
cancer	cancer	NN	I-NP	O
,	,	,	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
hypothyroidism	hypothyroidism	NN	B-NP	O
,	,	,	O	O
mitral	mitral	JJ	B-NP	O
valve	valve	NN	I-NP	O
repair	repair	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Sichel	Sichel	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
75-year-old	75-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
past	past	JJ	B-NP	O
medical	medical	JJ	I-NP	O
history	history	NN	I-NP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	O
of	of	IN	B-PP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
mitral	mitral	JJ	B-NP	O
valve	valve	NN	I-NP	O
repair	repair	NN	I-NP	O
in	in	IN	B-PP	O
11/26	11/26	CD	B-NP	O
,	,	,	O	O
lung	lung	NN	B-NP	B-protein
cancer	cancer	NN	I-NP	I-protein
likely	likely	RB	B-NP	I-protein
stage	stage	NN	I-NP	I-protein
IIIB	IIIB	NN	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
recently	recently	RB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
7/22/2006	7/22/2006	CD	B-NP	O
after	after	IN	B-PP	O
being	be	VBG	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
and	and	CC	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
and	and	CC	I-NP	O
hyperkalemia	hyperkalemia	NN	I-NP	O
.	.	.	O	O

Since	Since	IN	B-PP	O
being	be	VBG	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
7/22/2006	7/22/2006	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
reported	report	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
doing	do	VBG	I-VP	O
well	well	RB	B-ADVP	O
until	until	IN	B-PP	O
the	the	DT	B-NP	O
date	date	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
noticed	notice	VBD	B-VP	O
a	a	DT	B-NP	O
2.5-pound	2.5-pound	JJ	I-NP	O
weight	weight	NN	I-NP	O
gain	gain	NN	I-NP	O
,	,	,	O	O
increased	increase	VBD	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
with	with	IN	B-PP	O
activity	activity	NN	B-NP	O
and	and	CC	O	O
increased	increase	VBD	B-VP	O
oxygen	oxygen	NN	B-NP	O
requirement	requirement	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
reports	report	VBZ	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
normally	normally	RB	B-ADVP	O
uses	use	VBZ	B-VP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
of	of	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
needing	need	VBG	I-VP	O
the	the	DT	B-NP	O
oxygen	oxygen	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
reports	report	VBZ	B-VP	O
2	2	CD	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
substernal	substernal	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
which	which	WDT	B-NP	O
occurred	occur	VBD	B-VP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
radiation	radiation	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
nausea	nausea	NN	I-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
diaphoresis	diaphoresis	NN	B-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
lasted	last	VBD	B-VP	O
3	3	CD	B-NP	O
or	or	CC	I-NP	O
4	4	CD	I-NP	O
minutes	minute	NNS	I-NP	O
and	and	CC	O	O
resolved	resolve	VBN	B-VP	O
with	with	IN	B-PP	O
nitroglycerin	nitroglycerin	NN	B-NP	O
sublingual	sublingual	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
noted	note	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
urinating	urinate	VBG	I-VP	O
very	very	RB	B-ADVP	O
much	much	RB	I-ADVP	O
,	,	,	O	O
does	do	VBZ	B-VP	O
report	report	VB	I-VP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
taking	take	VBG	I-VP	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-SBAR	O
directed	direct	VBN	B-VP	O
at	at	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
thus	thus	RB	B-ADVP	O
called	call	VBD	B-VP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
cardiologist	cardiologist	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Bottex	Bottex	NNP	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
instructed	instruct	VBD	B-VP	O
her	her	PRP	B-NP	O
to	to	TO	B-VP	O
get	get	VB	I-VP	O
labs	lab	NNS	B-NP	O
drawn	draw	VBN	B-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
potassium	potassium	NN	B-NP	O
of	of	IN	B-PP	O
5.4	5.4	CD	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
2.3	2.3	CD	B-NP	O
and	and	CC	O	O
thus	thus	RB	O	O
was	be	VBD	B-VP	O
told	tell	VBN	I-VP	O
to	to	TO	I-VP	O
report	report	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ED	ED	NNP	I-NP	O
.	.	.	O	O

REVIEW	REVIEW	NNP	B-NP	O
OF	OF	IN	B-PP	O
SYSTEMS	SYSTEMS	NNP	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
denied	deny	VBD	B-VP	O
any	any	DT	B-NP	O
fever	fever	NN	I-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
or	or	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
,	,	,	O	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
diarrhea	diarrhea	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
rashes	rash	NNS	B-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Coronary	Coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
PCI	PCI	NN	I-NP	O
to	to	TO	B-PP	O
OM1	OM1	NN	B-NP	B-protein
in	in	IN	B-PP	O
1991	1991	CD	B-NP	O
,	,	,	O	O
LAD	LAD	NN	B-NP	B-protein
was	be	VBD	B-VP	O
stented	stente	VBN	I-VP	O
in	in	IN	B-PP	O
1997	1997	CD	B-NP	O
,	,	,	O	O
left	left	JJ	B-NP	O
circumflex	circumflex	NN	I-NP	O
was	be	VBD	B-VP	O
stented	stente	VBN	I-VP	O
in	in	IN	B-PP	O
2001	2001	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
was	be	VBD	B-VP	O
stented	stente	VBN	I-VP	O
in	in	IN	B-PP	O
2002	2002	CD	B-NP	O
;	;	:	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
dyslipidemia	dyslipidemia	NN	B-NP	O
;	;	:	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
with	with	IN	B-PP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	O
of	of	IN	B-PP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
-35	-35	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
dry	dry	JJ	I-NP	O
weight	weight	NN	I-NP	O
of	of	IN	B-PP	O
158	158	CD	B-NP	O
pounds	pound	NNS	I-NP	O
;	;	:	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
mitral	mitral	JJ	B-NP	O
valve	valve	NN	I-NP	O
repair	repair	NN	I-NP	O
in	in	IN	B-PP	O
10/18	10/18	CD	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
rate	rate	NN	B-NP	O
controlled	control	VBN	B-VP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
;	;	:	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
renal	renal	JJ	B-NP	O
artery	artery	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
status	status	NN	B-NP	O
post	post	IN	B-PP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
renal	renal	JJ	I-NP	O
artery	artery	NN	I-NP	O
stent	stent	NN	I-NP	O
;	;	:	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
baseline	baseline	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
1.9	1.9	CD	B-NP	O
to	to	TO	B-PP	O
2.2	2.2	CD	B-NP	O
;	;	:	O	O
GERD	GERD	NN	B-NP	O
;	;	:	O	O
peripheral	peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
;	;	:	O	O
iron	iron	NN	B-NP	O
deficiency	deficiency	NN	I-NP	O
anemia	anemia	NN	I-NP	O
;	;	:	O	O
bronchoalveolar	bronchoalveolar	JJ	B-NP	O
lung	lung	NN	I-NP	O
cancer	cancer	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
status	status	NN	B-NP	O
post	post	IN	B-PP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
and	and	CC	O	O
right	right	RB	B-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O
wedge	wedge	NN	I-NP	O
resections	resection	NNS	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
uterine	uterine	JJ	B-NP	O
cancer	cancer	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
status	status	NN	B-NP	O
post	post	IN	B-PP	O
a	a	DT	B-NP	O
TAH-BSO	TAH-BSO	NN	I-NP	B-protein
,	,	,	O	O
hypothyroidism	hypothyroidism	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
non-insulin-dependent	non-insulin-dependent	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

HOME	HOME	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Torsemide	Torsemide	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
allopurinol	allopurinol	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Ativan	Ativan	NNP	B-NP	O
0.5	0.5	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
,	,	,	O	O
ferrous	ferrous	JJ	B-NP	O
sulfate	sulfate	NN	I-NP	O
325	325	CD	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
glipizide	glipizide	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
isosorbide	isosorbide	NN	B-NP	O
dinitrate	dinitrate	NN	I-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
t.i.d.	t.i.d.	FW	I-ADVP	O
,	,	,	O	O
Levoxyl	Levoxyl	NNP	B-NP	O
100	100	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
multivitamin	multivitamin	NN	B-NP	O
1	1	CD	I-NP	O
tablet	tablet	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Nexium	Nexium	NNP	B-NP	O
20	20	CD	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
pravastatin	pravastatin	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
each	each	DT	B-NP	O
evening	evening	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Toprol	Toprol	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NNP	B-NP	O
EXAMINATION	EXAMINATION	NNP	I-NP	O
ON	ON	NNP	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
temperature	temperature	NN	I-NP	O
of	of	IN	B-PP	O
97.3	97.3	CD	B-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
of	of	IN	B-PP	O
80	80	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
146/76	146/76	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
16	16	CD	B-NP	O
.	.	.	O	O

O2	O2	NN	B-NP	O
saturation	saturation	NN	I-NP	O
of	of	IN	B-PP	O
96	96	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
moist	moist	JJ	B-NP	O
mucous	mucous	JJ	I-NP	O
membranes	membrane	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
oropharynx	oropharynx	NN	I-NP	O
was	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
pupil	pupil	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
enlarged	enlarge	VBN	I-VP	O
and	and	CC	O	O
nonreactive	nonreactive	JJ	B-ADJP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
being	be	VBG	B-VP	O
a	a	DT	B-NP	O
surgical	surgical	JJ	I-NP	O
eye	eye	NN	I-NP	O
.	.	.	O	O

Right	Right	NN	B-NP	O
eye	eye	NN	I-NP	O
was	be	VBD	B-VP	O
reactive	reactive	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
:	:	:	O	O
left	left	JJ	B-NP	O
side	side	NN	I-NP	O
was	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
right	right	JJ	I-NP	O
side	side	NN	I-NP	O
had	have	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
breath	breath	NN	B-NP	O
sounds	sound	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
base	base	NN	I-NP	O
,	,	,	O	O
few	few	JJ	B-NP	O
crackles	crackle	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
base	base	NN	I-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-NP	O
Examination	Examination	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
irregularly	irregularly	RB	B-NP	O
irregular	irregular	JJ	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
S1	S1	NN	I-NP	O
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
any	any	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	O	O
rubs	rub	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
gallops	gallop	NNS	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
flat	flat	JJ	I-NP	O
JVP	JVP	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Abdominal	Abdominal	JJ	B-NP	O
Examination	Examination	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
positive	positive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
soft	soft	JJ	B-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
,	,	,	I-NP	O
nondistended	nondistended	JJ	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
any	any	DT	B-NP	O
hepatomegaly	hepatomegaly	NN	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
warm	warm	JJ	B-ADJP	O
and	and	CC	O	O
well	well	RB	B-ADJP	O
perfused	perfuse	VBN	I-ADJP	O
.	.	.	O	O

Distal	Distal	JJ	B-NP	O
pulses	pulse	NNS	I-NP	O
were	be	VBD	B-VP	O
not	not	RB	O	O
palpable	palpable	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
trace	trace	NN	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-SBAR	O
right	right	NN	B-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
chronic	chronic	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
x3	x3	NN	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
BY	BY	NN	I-NP	O
PROBLEM	PROBLEM	NN	I-NP	O
:	:	:	O	O
Pulmonary/Oncology	Pulmonary/Oncology	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
requiring	require	VBG	I-VP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
of	of	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
to	to	TO	B-VP	O
keep	keep	VB	I-VP	O
her	her	PRP$	B-NP	O
saturations	saturation	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mid	mid	JJ	I-NP	O
90s	90	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
pleural	pleural	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
.	.	.	O	O

Review	Review	NN	B-NP	O
of	of	IN	B-PP	O
previous	previous	JJ	B-NP	O
imaging	imaging	NN	I-NP	O
done	do	VBN	B-VP	O
on	on	IN	B-PP	O
8/18/2006	8/18/2006	CD	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
an	an	DT	B-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
consolidation	consolidation	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
surrounded	surround	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
pleural	pleural	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
of	of	IN	B-PP	O
moderate	moderate	JJ	B-NP	O
size	size	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
PET	PET	NN	I-NP	O
scan	scan	NN	I-NP	O
in	in	IN	B-PP	O
early	early	JJ	B-NP	O
August	August	NNP	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
consolidation	consolidation	NN	I-NP	O
lit	light	VBD	B-VP	O
up	up	RP	B-PRT	O
extensively	extensively	RB	B-ADVP	O
.	.	.	O	O

Review	Review	NN	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
studies	study	NNS	I-NP	O
prompted	prompt	VBD	B-VP	O
consideration	consideration	NN	B-NP	O
of	of	IN	B-PP	O
possible	possible	JJ	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
versus	versus	IN	B-PP	O
a	a	DT	B-NP	O
bronchioalveolar	bronchioalveolar	JJ	I-NP	O
carcinoma	carcinoma	NN	I-NP	O
spread	spread	NN	I-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	NNP	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
and	and	CC	O	O
they	they	PRP	B-NP	O
suggested	suggest	VBD	B-VP	O
starting	start	VBG	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
on	on	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
for	for	IN	B-PP	O
possible	possible	JJ	B-NP	O
postobstructive	postobstructive	JJ	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
,	,	,	O	O
vancomycin	vancomycin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Flagyl	Flagyl	NN	B-NP	O
on	on	IN	B-PP	O
10/2/2006	10/2/2006	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
received	receive	VBD	B-VP	O
7	7	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
hospital	hospital	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
day	day	NN	B-NP	O
4	4	CD	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
thoracentesis	thoracentesis	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
for	for	IN	B-PP	O
both	both	CC	B-NP	O
diagnostic	diagnostic	JJ	I-NP	O
and	and	CC	I-NP	O
therapeutic	therapeutic	JJ	I-NP	O
reasons	reason	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
pleural	pleural	JJ	I-NP	O
fluid	fluid	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
a	a	DT	B-NP	O
transudative	transudative	JJ	I-NP	O
picture	picture	NN	I-NP	O
.	.	.	O	O

Gram	Gram	NN	B-NP	B-protein
stain	stain	NN	I-NP	I-protein
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Cultures	Culture	NNS	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
grow	grow	VB	I-VP	O
anything	anything	NN	B-NP	O
.	.	.	O	O

Cytology	Cytology	NN	B-NP	O
,	,	,	O	O
preliminary	preliminary	JJ	B-NP	O
read	read	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	B-cell_type
had	have	VBD	B-VP	I-cell_type
50	50	CD	B-NP	I-cell_type
white	white	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
2000	2000	CD	B-NP	O
red	red	JJ	I-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
approximately	approximately	RB	B-NP	O
800	800	CD	I-NP	O
mL	mL	NN	I-NP	O
were	be	VBD	B-VP	O
removed	remove	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
felt	feel	VBD	B-VP	O
much	much	RB	B-ADJP	O
less	less	RBR	I-ADJP	O
short	short	JJ	I-ADJP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
following	follow	VBG	B-PP	O
the	the	DT	B-NP	O
thoracentesis	thoracentesis	NN	I-NP	O
requiring	require	VBG	B-VP	O
much	much	RB	B-NP	O
less	less	JJR	I-NP	O
oxygen	oxygen	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
followup	followup	NN	I-NP	O
CT	CT	NN	I-NP	O
scan	scan	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
continued	continued	JJ	B-NP	O
infiltrate	infiltrate	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O
with	with	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
right	right	JJ	I-NP	O
pleural	pleural	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
pneumothorax	pneumothorax	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
.	.	.	O	O

Radiology	Radiology	NN	B-NP	O
felt	feel	VBD	B-VP	O
that	that	DT	O	O
her	her	PRP$	B-NP	O
consolidation	consolidation	NN	I-NP	O
was	be	VBD	B-VP	O
most	most	RBS	B-ADVP	O
likely	likely	RB	I-ADVP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
postobstructive	postobstructive	JJ	B-ADJP	O
given	give	VBN	B-PP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
bronchioles	bronchiole	NNS	I-NP	O
were	be	VBD	B-VP	O
in	in	IN	B-PP	O
fact	fact	NN	B-NP	O
quite	quite	RB	B-NP	O
patent	patent	NN	I-NP	O
and	and	CC	O	O
thus	thus	RB	B-ADVP	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
decided	decide	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
would	would	MD	B-VP	O
continue	continue	VB	I-VP	O
a	a	DT	B-NP	O
14-day	14-day	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
with	with	IN	B-PP	O
followup	followup	NN	B-NP	O
with	with	IN	B-PP	O
pulmonary	pulmonary	JJ	B-ADJP	O
to	to	TO	B-VP	O
consider	consider	VB	I-VP	O
whether	whether	IN	B-SBAR	O
or	or	CC	O	O
not	not	RB	O	O
a	a	DT	B-NP	O
bronchoscopy	bronchoscopy	NN	I-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
indicated	indicate	VBN	I-VP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
workup	workup	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
infiltrate	infiltrate	NN	I-NP	O
with	with	IN	B-PP	O
followup	followup	NN	B-NP	O
imaging	imaging	NN	I-NP	O
to	to	TO	B-VP	O
occur	occur	VB	I-VP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

Cardiovascularly	Cardiovascularly	RB	B-ADVP	O
,	,	,	O	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
patient	patient	NN	I-NP	O
,	,	,	O	O
ischemia	ischemia	NN	B-NP	O
wise	wise	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
2	2	CD	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
any	any	DT	B-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

Two	Two	CD	B-NP	O
sets	set	NNS	I-NP	O
of	of	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	B-protein
markers	marker	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
both	both	DT	O	O
negative	negative	JJ	O	O
,	,	,	O	O
thus	thus	RB	B-VP	O
assumed	assume	VBN	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
ischemic	ischemic	JJ	B-NP	O
event	event	NN	I-NP	O
that	that	WDT	B-NP	O
occurred	occur	VBD	B-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
aspirin	aspirin	NN	I-NP	O
and	and	CC	I-NP	O
pravastatin	pravastatin	NN	I-NP	O
while	while	IN	B-SBAR	O
inhouse	inhouse	NN	B-NP	O
.	.	.	O	O

Pump	Pump	NNP	B-NP	O
wise	wise	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
with	with	IN	B-PP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	O
of	of	IN	B-PP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
presented	present	VBD	B-VP	O
approximately	approximately	RB	B-NP	O
2	2	CD	I-NP	O
kg	kg	NN	I-NP	O
above	above	IN	B-PP	O
her	her	PRP$	B-NP	O
dry	dry	JJ	I-NP	O
weight	weight	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
torsemide	torsemide	NN	B-NP	O
40	40	CD	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
isosorbide	isosorbide	NN	I-NP	O
dinitrate	dinitrate	NN	I-NP	O
although	although	IN	B-SBAR	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
hydralazine	hydralazine	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
and	and	CC	O	O
did	do	VBD	B-VP	O
diurese	diurese	VB	I-VP	O
approximately	approximately	RB	B-NP	O
500	500	CD	I-NP	O
mL	mL	NN	I-NP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
liter	liter	NN	I-NP	O
each	each	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
returned	return	VBD	B-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
dry	dry	JJ	I-NP	O
weight	weight	NN	I-NP	O
and	and	CC	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
weight	weight	NN	I-NP	O
of	of	IN	B-PP	O
72.6	72.6	CD	B-NP	O
kg	kg	NN	I-NP	O
,	,	,	O	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
dry	dry	JJ	I-NP	O
weight	weight	NN	I-NP	O
of	of	IN	B-PP	O
74.9	74.9	CD	B-NP	O
kg	kg	NN	I-NP	O
.	.	.	O	O

Rhythm	Rhythm	NN	B-NP	O
wise	wise	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
rate	rate	NN	B-NP	O
controlled	control	VBN	B-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
metoprolol	metoprolol	NN	I-NP	O
37.5	37.5	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
except	except	IN	B-PP	O
for	for	IN	B-PP	O
brief	brief	JJ	B-NP	O
period	period	NN	I-NP	O
during	during	IN	B-PP	O
which	which	WDT	B-NP	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
tap	tap	NN	I-NP	B-protein
of	of	IN	B-PP	O
this	this	DT	B-NP	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

Endocrine	Endocrine	JJ	B-NP	O
wise	wise	NN	I-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
fingersticks	fingerstick	NNS	I-NP	O
were	be	VBD	B-VP	O
well	well	RB	I-VP	O
controlled	control	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
put	put	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
Lantus	Lantus	NNP	B-NP	O
and	and	CC	I-NP	O
NovoLog	NovoLog	NNP	I-NP	O
q.a.c.	q.a.c.	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

Fingersticks	Fingerstick	NNS	B-NP	O
were	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
within	within	IN	B-PP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
range	range	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
Levoxyl	Levoxyl	NN	I-NP	O
was	be	VBD	B-VP	O
100	100	CD	B-NP	O
mcg	mcg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
allopurinol	allopurinol	NN	I-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
gout	gout	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
put	put	VBN	I-VP	O
back	back	RB	B-ADVP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
glipizide	glipizide	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
diabetes	diabetes	NN	I-NP	O
.	.	.	O	O

Fluid	Fluid	NN	B-NP	O
,	,	,	O	O
electrolytes	electrolyte	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
nutrition	nutrition	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
came	come	VBD	B-VP	O
in	in	IN	B-PP	O
hyperkalemic	hyperkalemic	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
Kayexalate	Kayexalate	NNP	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
x1	x1	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
to	to	TO	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
responded	respond	VBD	B-VP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
potassium	potassium	NN	I-NP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
.	.	.	O	O

For	For	IN	B-PP	O
this	this	DT	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
diuresis	diuresis	NN	I-NP	O
she	she	PRP	B-NP	O
did	do	VBD	B-VP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
addition	addition	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hydralazine	hydralazine	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
drop	drop	NN	I-NP	O
from	from	IN	B-PP	O
2.2	2.2	CD	B-NP	O
down	down	IN	B-ADVP	O
to	to	TO	B-PP	O
1.7	1.7	CD	B-NP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
admission	admission	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
1.9	1.9	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
within	within	IN	B-PP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
chronic	chronic	JJ	I-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

Hematology	Hematology	NNP	B-NP	O
wise	wise	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
stable	stable	JJ	I-NP	O
hematocrit	hematocrit	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
low	low	JJ	I-NP	O
30s	30	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
iron	iron	NN	I-NP	O
325	325	CD	I-NP	O
twice	twice	RB	I-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
iron	iron	NN	I-NP	O
deficiency	deficiency	NN	I-NP	O
anemia	anemia	NN	I-NP	O
.	.	.	O	O

LENI	LENI	NNP	B-NP	O
's	's	POS	B-NP	O
also	also	RB	B-ADVP	O
performed	perform	VBD	B-VP	O
and	and	CC	I-VP	O
showed	show	VBD	I-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
DVT	DVT	NN	B-NP	B-protein
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
notable	notable	JJ	B-NP	O
findings	finding	NNS	I-NP	O
on	on	IN	B-PP	O
physical	physical	JJ	B-NP	O
exam	exam	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
.	.	.	O	O

Heart	Heart	NN	B-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
71	71	CD	B-NP	O
to	to	TO	B-PP	O
85	85	CD	B-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
100-114	100-114	CD	I-NP	O
over	over	IN	B-PP	O
40-66	40-66	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
saturating	saturate	VBG	I-VP	O
93	93	CD	B-NP	O
%	%	NN	I-NP	O
to	to	TO	B-PP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-NP	O
Examination	Examination	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
irregularly	irregularly	RB	B-ADJP	O
irregular	irregular	JJ	I-ADJP	O
.	.	.	O	O

S1	S1	NN	B-NP	B-protein
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
were	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	O	O
rubs	rub	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
gallops	gallop	NNS	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
JVP	JVP	NN	I-NP	B-protein
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
9	9	CD	B-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

Examination	Examination	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
lungs	lung	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
they	they	PRP	B-NP	O
were	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
left	left	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
right	right	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
crackles	crackle	NNS	B-NP	O
approximately	approximately	RB	B-ADVP	O
halfway	halfway	VBP	B-VP	O
up	up	RP	B-PRT	O
,	,	,	O	O
but	but	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
decreased	decrease	VBN	I-VP	O
breath	breath	NN	B-NP	O
sounds	sound	VBZ	B-VP	O
as	as	IN	B-SBAR	O
noted	note	VBN	B-VP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
any	any	DT	B-NP	O
pitting	pit	VBG	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
81	81	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
,	,	,	O	O
allopurinol	allopurinol	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
ferrous	ferrous	JJ	B-NP	O
sulfate	sulfate	NN	I-NP	O
325	325	CD	B-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
glipizide	glipizide	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
isosorbide	isosorbide	NN	B-NP	O
dinitrate	dinitrate	NN	I-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
3	3	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Levoxyl	Levoxyl	NN	B-NP	O
100	100	CD	I-NP	O
mcg	mcg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Toprol	Toprol	NNP	B-NP	O
XL	XL	NNP	I-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
multivitamin	multivitamin	NN	B-NP	O
1	1	CD	I-NP	O
tablet	tablet	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
pravastatin	pravastatin	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
,	,	,	O	O
torsemide	torsemide	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Nexium	Nexium	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
,	,	,	O	O
levofloxacin	levofloxacin	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
,	,	,	O	O
q.	q.	NN	B-NP	O
48h	48h	NN	I-NP	O
.	.	.	O	O

for	for	IN	B-PP	O
a	a	DT	B-NP	O
total	total	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
4	4	CD	B-NP	O
more	more	JJR	I-NP	O
doses	dose	NNS	I-NP	O
,	,	,	O	O
hydralazine	hydralazine	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
3	3	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Ativan	Ativan	IN	B-ADVP	O
0.5	0.5	CD	B-NP	O
mg	mg	NN	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

PENDING	PENDING	VBG	B-VP	O
TESTS	TESTS	NNS	B-NP	O
:	:	:	O	O
Final	Final	JJ	B-NP	O
pathology	pathology	NN	I-NP	O
report	report	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
cytology	cytology	NN	I-NP	O
studies	study	NNS	I-NP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
thoracentesis	thoracentesis	NN	I-NP	O
is	be	VBZ	B-VP	O
still	still	RB	I-VP	O
pending	pende	VBG	I-VP	O
.	.	.	O	O

FOLLOWUP	FOLLOWUP	NN	B-NP	O
PLANS	PLANS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Theo	Theo	NNP	I-NP	O
Damien	Damien	NNP	I-NP	O
on	on	IN	B-PP	O
5/27/2006	5/27/2006	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
followup	followup	NN	I-NP	O
with	with	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
medicine	medicine	NN	I-NP	O
on	on	IN	B-PP	O
10/1/2006	10/1/2006	CD	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Cahue	Cahue	NNP	I-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
DURING	DURING	NNP	I-NP	O
THIS	THIS	NNP	I-NP	O
ADMISSION	ADMISSION	NNP	I-NP	O
:	:	:	O	O
Do	Do	NNP	B-NP	O
not	not	RB	B-VP	O
resuscitate	resuscitate	VB	I-VP	O
,	,	,	O	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
intubate	intubate	VB	I-VP	O
.	.	.	O	O

PRIMARY	PRIMARY	NN	B-NP	O
CARE	CARE	NN	I-NP	O
PHYSICIAN	PHYSICIAN	NN	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Clayton	Clayton	NNP	I-NP	O
Kerrick	Kerrick	NNP	I-NP	O
eScription	eScription	NN	I-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
8-4550862	8-4550862	CD	B-NP	O
HFFocus	HFFocus	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
FINKBEINER	FINKBEINER	NNP	B-NP	O
,	,	,	O	O
ESTEBAN	ESTEBAN	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
GOLIDAY	GOLIDAY	NNP	B-NP	O
,	,	,	O	O
ALEXIS	ALEXIS	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
1149846	1149846	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
10/21/06	10/21/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
11/29/06	11/29/06	CD	B-NP	O

